FDMT vs L · rev $37.0K vs P/E 14, rev $18.45B
4D Molecular Therapeutics Inc (FDMT) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
FDMT currently screens at market cap $518.1M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the FDMT and L stock pages for the full models.
Not investment advice.